COMP <GO>
BMI vs ESAB // EV/EBITDA & P/E VALUATION
Badger Meter Inc. (NYSE) VS. ESAB Corporation (NYSE) • 15-METRIC TALLY: BMI 10
— ESAB 4
▲ EV/EBITDA & P/E VALUATION LEADER: ESAB
LAST: $157.69 (+6.27%) • MKT CAP: $4.24B
valuation
22.3x
LAST: $76.30 (+9.38%) • MKT CAP: $4.34B
valuation
12.5x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (BMI VS. ESAB)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | BMI | ESAB | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 41.70% | 36.90% | +4.80 | BMI | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 18.30% | 10.10% | +8.20 | BMI | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 22.3x | 12.5x | +9.80 | ESAB | /valuation <GO> |
| Free Cash Flow Yield | 3.97% | 4.63% | -0.66 | ESAB | /fcf-yield <GO> |
| Operating Margin | 20.00% | 14.50% | +5.50 | BMI | /operating-margins <GO> |
| Net Profit Margin | 15.50% | 8.00% | +7.50 | BMI | /net-margins <GO> |
| Revenue Growth (YoY) | 10.90% | 3.70% | +7.20 | BMI | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 1.02% | 0.48% | +0.54 | BMI | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 8.42 | 2.35 | +6.07 | BMI | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 7/9 | +2.00 | BMI | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 61.3 | 50.5 | +10.80 | BMI | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.14 | 0.89 | +0.25 | BMI | /macro-sensitivity <GO> |
| Forward P/E Multiple | 28.1x | 18.9x | +9.20 | ESAB | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $4.24B | $4.34B | -$98.6M | ESAB | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | BMI REV | ESAB REV | BMI GROSS % | ESAB GROSS % | BMI FCF | ESAB FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $916.7M | $2.84B | 41.7% | 36.9% | $169.7M | $213.3M |
| FY 2024 | $826.6M | $2.74B | 39.8% | 37.9% | $142.2M | $303.6M |
| FY 2023 | $703.6M | $2.77B | — | — | $78.5M | $205.6M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
BMI // BETA 1.14
ESAB // BETA 0.89